Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» New anti-PD1 drugs overpriced, ICER says
New anti-PD1 drugs overpriced, ICER says
New anti-PD1 drugs overpriced, ICER says
Submitted by
admin
on October 6, 2016 - 9:37am
Source:
BioPharma Dive
News Tags:
drug pricing
ICER
anti-PD-L1
Opdivo
Keytruda
Bristol-Myers Squibb
Merck
Headline:
New anti-PD1 drugs overpriced, ICER says
Do Not Allow Advertisers to Use My Personal information
